Literature DB >> 21528831

Interactive financial decision support for clinical research trials.

Benjamin Holler1, Dana A Forgione, Clinton E Baisden, David A Abramson, John H Calhoon.   

Abstract

The purpose of this article is to describe a decision support approach useful for evaluating proposals to conduct clinical research trials. Physicians often do not have the time or background to account for all the expenses of a clinical trial. Their evaluation process may be limited and driven by factors that do not indicate the potential for financial losses that a trial may impose. We analyzed clinical trial budget templates used by hospitals, health science centers, research universities, departments of medicine, and medical schools. We compiled a databank of costs and reviewed recent research trials conducted by the Department of Cardiothoracic Surgery in a major academic health science center. We then developed an interactive spreadsheet-based budgetary decision support approach that accounts for clinical trial income and costs. It can be tailored to provide quick and understandable data entry, accurate cost rates per subject, and clear go/no-go signals for the physician.

Mesh:

Year:  2011        PMID: 21528831

Source DB:  PubMed          Journal:  J Health Care Finance        ISSN: 1078-6767


  3 in total

1.  The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.

Authors:  Paula H Song; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Ann Scheck McAlearney
Journal:  Health Care Manage Rev       Date:  2013 Oct-Dec

2.  The strategic case for establishing public-private partnerships in cancer care.

Authors:  Debra J Holden; Kristin Reiter; Donna O'Brien; Kathleen Dalton
Journal:  Health Res Policy Syst       Date:  2015-10-14

3.  Comparative costs and activity from a sample of UK clinical trials units.

Authors:  Daniel Hind; Barnaby C Reeves; Sarah Bathers; Christopher Bray; Andrea Corkhill; Christopher Hayward; Lynda Harper; Vicky Napp; John Norrie; Chris Speed; Liz Tremain; Nicola Keat; Mike Bradburn
Journal:  Trials       Date:  2017-05-02       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.